Cullinan Associates Inc
Source: SEC Form 13F · as of Mar 2026Cullinan Associates Inc holds 16 biotech & pharma companies tracked by BioSniper, totaling $119.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$119.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 183,038 | $44.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 51,762 | $23.1M |
| ABBVAbbVie Inc. | 73,455 | $16.0M |
| AMGNAMGEN INC | 25,516 | $9.0M |
| LLYELI LILLY & Co | 6,978 | $6.4M |
| MRKMerck & Co., Inc. | 48,045 | $5.8M |
| PMPhilip Morris International Inc | 29,355 | $4.9M |
| ABTABBOTT LABORATORIES | 26,500 | $2.7M |
| BMYBRISTOL MYERS SQUIBB CO | 42,219 | $2.6M |
| PFEPFIZER INC | 46,101 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,154 | $1.1M |
| NVSNovartis AG | 4,700 | $718K |
| GILDGILEAD SCIENCES, INC. | 4,286 | $597K |
| NVONovo Nordisk A/S | 8,675 | $319K |
| ZTSZoetis Inc. | 2,500 | $296K |
| BAXBaxter International Inc. | 13,200 | $222K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.